Long Beach, NY, United States of America

John Baxter Biggins

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: John Baxter Biggins: Innovator in Therapeutic Technologies

Introduction

John Baxter Biggins is a notable inventor based in Long Beach, NY (US). He has made significant contributions to the field of therapeutic technologies, particularly in identifying human therapeutic targets and modulators derived from fungi. With a total of 2 patents, his work is paving the way for advancements in drug development.

Latest Patents

Biggins' latest patents focus on "Human therapeutic targets and modulators thereof." These patents provide technologies for the efficient and effective identification of ETaGs, particularly from fungi genomes. The technologies are designed to identify mammalian targets of biosynthetic products of fungi. They are particularly useful for prioritizing human targets for drug development and for developing modulators based on these biosynthetic products.

Career Highlights

John Baxter Biggins is currently associated with Lifemine Therapeutics, Inc., where he continues to innovate in the field of therapeutic technologies. His work is instrumental in advancing the understanding of how fungal products can be utilized in human medicine.

Collaborations

Biggins collaborates with notable professionals in his field, including Brian Roger Bowman and Gregory Lawrence Verdine. Their combined expertise contributes to the success of their projects and the advancement of therapeutic technologies.

Conclusion

John Baxter Biggins is a prominent inventor whose work in therapeutic technologies is making a significant impact in drug development. His innovative approaches and collaborations are essential for the future of medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…